Vnitr Lek 2011, 57(2):155-158

Relationship of the CDKAL1 and KCNQ1 gene polymorphisms to the age at diagnosis of type 2 diabetes in the Slovakian population

M. Dobríková1, M. Javorský1, V. Habálová2, L. Klimčáková2, M. Kozárová1, J. Židzik2, J. Halušková2, J. Šalagovič2, I. Tkáč1,*
1 IV. interná klinika Lekárskej fakulty UPJŠ a Centra excelentnosti pre výskum aterosklerózy a jej komplikácií - srdcového a mozgového infarktu (CEVA) Lekárskej fakulty UPJŠ Košice, Slovenská republika, prednosta prof. MUDr. Ivan Tkáč, PhD.
2 Ústav lekárskej biológie Lekárskej fakulty UPJŠ a Centra excelentnosti pre výskum aterosklerózy a jej komplikácií - srdcového a mozgového infarktu (CEVA) Lekárskej fakulty UPJŠ v Košice, Slovenská republika, prednosta prof. RNDr. Ján Šalagovič, PhD.

Background/aims:
The association of CDKAL1 and KCNQ1 genes with type 2 diabetes mellitus (DM2T) was confirmed by several genome-wide association studies in both Caucasian and Asian populations. For both genes, it is supposed that the risk of DM2T development is related to impaired insulin secretion. Based on assumption that the presence of risk allele might predispose to an earlier onset of DM2T, the aim of the present study was to assess the frequency of risk alleles of CDKAL1 rs7756992 and KCNQ1 rs163184 polymorphisms and to analyze their association with the age at DM2T diagnosis in the Slovakian population.

Methods:
CDKAL1 rs7756992 A/G and KCNQ1 rs163184 G/T polymorphisms were genotyped using asymmetric PCR with subsequent melting curve analysis in a group of 538 patients with DM2T. Anthropometric and laboratory parameters were determined by using standard methods. Since two genes were analysed, the required level for statistical significance was defined as p < 0.025.

Results:
Risk homozygotes (GG) for KCNQ1 polymorphism had higher mean age of DM2T diagnosis by 2 years when compared to T-allele carriers (GT + TT) in a recessive model, but the difference did not reach the predefined level of statistical significance. No relationship of CDKAL1 polymorphism to the age at onset of DM2T diagnosis was observed.

Conclusions:
In the present study, no relationship of CDKAL1 and KCNQ1 polymorphisms to the earlier onset of type 2 diabetes was observed.

Keywords: type 2 diabetes mellitus; gene polymorphisms; CDKAL1; KCNQ1; age at diagnosis of diabetes

Received: April 15, 2010; Accepted: November 23, 2010; Published: February 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dobríková M, Javorský M, Habálová V, Klimčáková L, Kozárová M, Židzik J, et al.. Relationship of the CDKAL1 and KCNQ1 gene polymorphisms to the age at diagnosis of type 2 diabetes in the Slovakian population. Vnitr Lek. 2011;57(2):155-158.
Download citation

References

  1. Ubeda M, Rukstalis JM, Habener JF. Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity. J Biol Chem 2006; 281: 28858-28864. Go to original source... Go to PubMed...
  2. Ridderstråle M, Groop L. Genetic dissection of type 2 diabetes. Mol Cell Endocrinol 2009; 297: 10-17. Go to original source... Go to PubMed...
  3. Tabara Y, Osawa H, Kawamoto R et al. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes 2009; 58: 493-498. Go to original source... Go to PubMed...
  4. Wu Y, Li H, Loos RJ et al. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes 2008; 57: 2834-2842. Go to original source... Go to PubMed...
  5. Horikoshi M, Hara K, Ito C et al. Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population. Diabetologia 2007; 50: 2461-2466. Go to original source... Go to PubMed...
  6. Steinthorsdottir V, Thorleifsson G, Reynisdottir I et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007; 39: 770-775. Go to original source... Go to PubMed...
  7. Kirchhoff K, Machicao F, Haupt A et al. Polymorphisms in TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 2008; 51: 597-601. Go to original source... Go to PubMed...
  8. Stančáková A, Kuulasmaa T, Paananen J et al. Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5327 non-diabetic Finnish men. Diabetes 2009; 58: 2129-2136. Go to original source... Go to PubMed...
  9. Unoki H, Takahashi A, Kawaguchi T et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet 2008; 40: 1098-1102. Go to original source... Go to PubMed...
  10. Ullrich S, Su J, Ranta F et al. Effects of I (Ks) channels inhibitors in insulin-secreting INS-1 cells. Pflugers Arch 2005; 451: 428-436. Go to original source... Go to PubMed...
  11. Yasuda K, Miyake K, Horikawa Y et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 2008; 40: 1092-1097. Go to original source... Go to PubMed...
  12. Lee Y, Kang ES, Kim SH et al. Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population. J Hum Genet 2008; 53: 991-998. Go to original source... Go to PubMed...
  13. Müssig K, Staiger H, Machicao F et al. Association of type 2 diabetes candidate polymorphisms in KCNQ1 with incretin and insulin secretion. Diabetes 2009; 58: 1715-1720. Go to original source... Go to PubMed...
  14. Cauchi S, Meyre D, Dina C et al. Transcription factor TCF7L2 genetics study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 2006; 55: 2903-2908. Go to original source... Go to PubMed...
  15. Lehman DM, Hunt KJ, Leach RJ et al. Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans. Diabetes 2007; 56: 389-393. Go to original source... Go to PubMed...
  16. Kimber CH, Doney AS, Pearson ER et al. TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels. Diabetologia 2007; 50: 1186-1191. Go to original source... Go to PubMed...
  17. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197. Go to original source... Go to PubMed...
  18. Solé X, Guinó E, Valls J et al. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006; 22: 1928-1929. Go to original source... Go to PubMed...
  19. Tong Y, Lin Y, Zhang Y et al. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med Genet 2009; 10: 15. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.